JP2019517262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517262A5 JP2019517262A5 JP2018563152A JP2018563152A JP2019517262A5 JP 2019517262 A5 JP2019517262 A5 JP 2019517262A5 JP 2018563152 A JP2018563152 A JP 2018563152A JP 2018563152 A JP2018563152 A JP 2018563152A JP 2019517262 A5 JP2019517262 A5 JP 2019517262A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- pharmaceutical composition
- seq
- aare
- nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims 23
- 102000039446 nucleic acids Human genes 0.000 claims 23
- 150000007523 nucleic acids Chemical class 0.000 claims 23
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 101710163270 Nuclease Proteins 0.000 claims 5
- 108091033319 polynucleotide Proteins 0.000 claims 4
- 102000040430 polynucleotide Human genes 0.000 claims 4
- 239000002157 polynucleotide Substances 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 3
- 108091027981 Response element Proteins 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 108091033409 CRISPR Proteins 0.000 claims 1
- 206010064571 Gene mutation Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003797 essential amino acid Substances 0.000 claims 1
- 235000020776 essential amino acid Nutrition 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022110001A JP2022133441A (ja) | 2016-06-03 | 2022-07-07 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16172964 | 2016-06-03 | ||
| EP16172964.5 | 2016-06-03 | ||
| PCT/EP2017/063549 WO2017207797A1 (en) | 2016-06-03 | 2017-06-02 | Diet controlled expression of a nucleic acid encoding cas9 nuclease and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022110001A Division JP2022133441A (ja) | 2016-06-03 | 2022-07-07 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019517262A JP2019517262A (ja) | 2019-06-24 |
| JP2019517262A5 true JP2019517262A5 (enExample) | 2020-07-02 |
| JP7436145B2 JP7436145B2 (ja) | 2024-02-21 |
Family
ID=56148119
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018563152A Active JP7436145B2 (ja) | 2016-06-03 | 2017-06-02 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
| JP2022110001A Pending JP2022133441A (ja) | 2016-06-03 | 2022-07-07 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022110001A Pending JP2022133441A (ja) | 2016-06-03 | 2022-07-07 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20190185832A1 (enExample) |
| JP (2) | JP7436145B2 (enExample) |
| KR (1) | KR102317622B1 (enExample) |
| CN (2) | CN116064534A (enExample) |
| AU (1) | AU2017275769B2 (enExample) |
| BR (1) | BR112018074930A2 (enExample) |
| CA (1) | CA3025591A1 (enExample) |
| IL (1) | IL263291B2 (enExample) |
| RU (1) | RU2771383C2 (enExample) |
| SG (1) | SG11201810772XA (enExample) |
| WO (1) | WO2017207797A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3823995A4 (en) * | 2018-08-01 | 2022-05-04 | The Regents of the University of Colorado, a body corporate | PROGRAMMABLE THERAPEUTIC FUSOGENE SECRETED GECTOSOME DESIGNER VESICLES FOR MACROMOLECULE RELEASE AND GENOME MODIFICATION |
| CN112442528B (zh) * | 2019-08-30 | 2022-08-12 | 深圳华大基因股份有限公司 | Loxhd1基因突变体及其应用 |
| CN114058689B (zh) * | 2020-07-30 | 2024-08-20 | 南京市妇幼保健院 | 一种基因突变检测试剂盒及其应用 |
| CN119894540A (zh) * | 2022-07-05 | 2025-04-25 | 营养治疗基因公司 | 人类t或nk细胞中转基因的受控表达用于细胞免疫疗法 |
| WO2024100176A1 (en) * | 2022-11-10 | 2024-05-16 | Nutritheragene | Controlled gene therapy of ocular diseases |
| CN116732043B (zh) * | 2023-08-10 | 2023-10-17 | 四川省医学科学院·四川省人民医院 | 一种突变基因及其白内障筛查的用途与白内障筛查试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2982277B1 (fr) * | 2011-11-08 | 2015-08-21 | Agronomique Inst Nat Rech | Cassette d'expression inductible et ses utilisations |
| ES2713243T3 (es) * | 2012-12-06 | 2019-05-20 | Sigma Aldrich Co Llc | Modificación y regulación del genoma basada en CRISPR |
| US20150098954A1 (en) * | 2013-10-08 | 2015-04-09 | Elwha Llc | Compositions and Methods Related to CRISPR Targeting |
| EP3080261B1 (en) | 2013-12-12 | 2019-05-22 | The Broad Institute, Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for hbv and viral diseases and disorders |
| KR20250068794A (ko) | 2013-12-12 | 2025-05-16 | 더 브로드 인스티튜트, 인코퍼레이티드 | 게놈 편집을 위한 ｃｒｉｓｐｒ-ｃａｓ 시스템 및 조성물의 전달, 용도 및 치료적 응용 |
-
2017
- 2017-06-02 KR KR1020197000200A patent/KR102317622B1/ko active Active
- 2017-06-02 JP JP2018563152A patent/JP7436145B2/ja active Active
- 2017-06-02 CN CN202211117939.7A patent/CN116064534A/zh active Pending
- 2017-06-02 AU AU2017275769A patent/AU2017275769B2/en active Active
- 2017-06-02 CA CA3025591A patent/CA3025591A1/en active Pending
- 2017-06-02 US US16/304,988 patent/US20190185832A1/en not_active Abandoned
- 2017-06-02 RU RU2018142174A patent/RU2771383C2/ru active
- 2017-06-02 WO PCT/EP2017/063549 patent/WO2017207797A1/en not_active Ceased
- 2017-06-02 CN CN201780045274.4A patent/CN109906271A/zh active Pending
- 2017-06-02 BR BR112018074930-3A patent/BR112018074930A2/pt not_active Application Discontinuation
- 2017-06-02 SG SG11201810772XA patent/SG11201810772XA/en unknown
-
2018
- 2018-11-26 IL IL263291A patent/IL263291B2/en unknown
-
2022
- 2022-07-07 JP JP2022110001A patent/JP2022133441A/ja active Pending
-
2023
- 2023-01-12 US US18/153,490 patent/US20230313161A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019517262A5 (enExample) | ||
| JP2018520997A5 (enExample) | ||
| RU2018142174A (ru) | Контролируемая пищевым рационом экспрессия нуклеиновой кислоты, кодирующей нуклеазу cas9, и ее применения | |
| JP2016538885A5 (enExample) | ||
| JP2016501532A5 (enExample) | ||
| JP2008541759A5 (enExample) | ||
| JP2011528896A5 (enExample) | ||
| JP2015510393A5 (enExample) | ||
| JP2019525744A5 (enExample) | ||
| JP2020518276A5 (enExample) | ||
| JP2008536483A5 (enExample) | ||
| JP2019523648A5 (enExample) | ||
| JP2017006120A5 (enExample) | ||
| WO2011126808A3 (en) | Pharmacologically induced transgene ablation system | |
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| JP2020023567A5 (enExample) | ||
| JP2015517489A5 (enExample) | ||
| JP2013172743A5 (enExample) | ||
| JP2012115277A5 (enExample) | ||
| JP2016513115A5 (enExample) | ||
| JP2016527891A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JP2017529326A5 (enExample) | ||
| JP2020073536A5 (enExample) | ||
| JP2017221201A5 (enExample) |